Operon Strategist as a reliable medical device consultant assists companies and medical device manufacturers by providing consulting services that support the registration of drug -device Combination Products. We have experience with each constituent part and the GMP regulations that together form the basis for their development and manufacture: Drug (21 CFR 210/211), Device (21 CFR 820) and 21 CFR Combination Products (21 CFR Part 4). We also service clients in Saudi Arabia.




Quick Links


  Post Your Article

  Browse Articles

  Contact Us

Copyright © 2023, All Rights Reserved

Back to Top